ViroVet develops antiviral drugs and thermostable vaccines (PLLAV) for controlling viral diseases in livestock, particularly in cattle and swine.
ViroVet is a company dedicated to developing technologies for viral disease control in livestock. The company's pipeline includes antiviral drugs for respiratory disease complexes and PLLAV vaccines—modified live virus vaccines that eliminate cold chain requirements. ViroVet has antiviral solutions for diseases like BVD and ASF.